Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Vision Medicals, a China-based gene-sequencing technology developer backed by Chinese Academy of Sciences, has raised RMB300m ($47m) in a series D round featuring internet and gaming group Tencent, DealStreetAsia reported today, citing a company statement. Boyu Capital, CDH Venture and Growth Capital, a vehicle for alternative asset management firm CDH, also took part in the round. Cash Capital, an investment vehicle for Chinese Academy of Sciences, was among the investors in a $30.9m series C round in February 2021.

Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.